REQUEST A DEMO
Total
USD $0.00
Search more companies

Medipal-Onko OOO (Russia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Medipal-Onko OOO Profile Updated: August 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Medipal-Onko OOO is based in Russia, with the head office in Moscow. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The enterprise was incorporated on September 23, 2002. The latest financial highlights indicate a net sales revenue increase of 21.43% in 2023. Its’ total assets recorded a growth of 37.75%. The enterprise’s net profit margin increased by 0.44% in 2023.

Headquarters
Fridriha Engelisa, 75, 21, 216
Moscow; Moscow; Postal Code: 105082

Contact Details: Purchase the Medipal-Onko OOO report to view the information.

Website: http://medipal-onko.ru

Basic Information
Outstanding Shares:
Purchase the Medipal-Onko OOO report to view the information.
Registered Capital:
Purchase the Medipal-Onko OOO report to view the information.
Incorporation Date:
September 23, 2002
Key Executives
Purchase this report to view the information.
Management Company
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Medipalteh OOO
50%
Company Performance
Financial values in the chart are available after Medipal-Onko OOO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
21.43%
Total operating revenue
21.43%
Operating profit (EBIT)
2.19%
Net Profit (Loss) for the Period
33.32%
Total assets
37.75%
Total equity
-0.47%
Operating Profit Margin (ROS)
-0.97%
Net Profit Margin
0.44%
Return on Equity (ROE)
9.8%
Quick Ratio
-0.45%
Cash Ratio
-0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?